| Literature DB >> 32211050 |
Simeon-Pierre Choukem1,2,3, Joel Noutakdie Tochie2,4, Aurelie T Sibetcheu2,5, Jobert Richie Nansseu2,6, Julian P Hamilton-Shield7.
Abstract
INTRODUCTION: Recently, childhood and adolescence overweight/obesity has increased disproportionately in developing countries, with estimates predicting a parallel increase in future cardiovascular disease (CVD) burden identifiable in childhood and adolescence. Identifying cardiovascular risk factors (CVRF) associated with childhood and adolescence overweight/obesity is pivotal in tailoring preventive interventions for CVD. Whilst this has been examined extensively in high-income countries, there is scant consistent or representative data from sub-Saharan Africa (SSA).Entities:
Keywords: Adolescent; Cardiovascular risk factor; Children; Obesity; Overweight; Sub-Saharan Africa
Year: 2020 PMID: 32211050 PMCID: PMC7092532 DOI: 10.1186/s13633-020-0076-7
Source DB: PubMed Journal: Int J Pediatr Endocrinol ISSN: 1687-9848
Search strategy for MEDLINE and adaptability to Google scholar data base
| Region/Country | sub Saharan Africa OR sub Saharan African OR subSaharan Africa OR Angola OR Benin OR Botswana OR Burkina Faso OR Burundi OR Cameroon OR Cape Verde OR Central African Republic OR Chad OR Comoros OR Congo OR Democratic Republic of Congo OR Djibouti OR Equatorial Guinea OR Eritrea OR Ethiopia OR Gabon OR Gambia OR Ghana OR Guinea OR Guinea-Bissau OR Ivory Coast OR Kenya OR Lesotho OR Liberia OR Madagascar OR Malawi OR Mali OR Mauritania OR Mauritius OR Mozambique OR Namibia OR Niger OR Nigeria ORPrincipe OR Reunion OR Rwanda OR Sao Tome OR Senegal OR Seychelles OR Sierra Leone OR Somalia OR South Africa OR Sudan OR Swaziland OR Tanzania OR Togo OR Uganda ORWestern Sahara OR Zambia OR Zimbabwe OR Central Africa OR Central African OR West Africa OR West African OR Western Africa OR Western African OR East Africa OR East African OR Eastern Africa OR Eastern African OR South African OR Southern Africa OR Southern African. |
| Disease/Risk factor | Cardiovascular risk factor OR hypertension OR high blood pressure OR elevated blood pressure OR salt intake OR diabetes OR artherosclerosis OR glucose intolerance OR dyslipidemia OR cholesterol OR triglyceride OR smoking OR tobacco OR alcohol consumption OR physical inactivity OR lack of exercise OR diet OR nutrition OR urbanization OR socio-economic status OR lack of sleep OR sleep apnoea. |
| Participants | Children OR child OR childhood OR infants OR toddlers OR adolescents OR adolescence OR obesity OR obese OR overweightOR nutritional status OR fat OR fatness OR adiposity OR fatty OR body size |
Fig. 1Flow diagram of study selection
International cut-off values for childhood overweight and obesity
| International cut-offs | Age group | Cut-off |
|---|---|---|
| WHO growth standard [ | < 5 year | Overweight: + 2SD ≤ BMI < +3SD Obesity: BMI ≥ + 3 SD |
| 5–19 years old | Overweight: +1SD < BMI < + 2SD Obesity: BMI > +2 SD | |
| Centre for Diseases Control [ | 2–19 years old | Overweight = 85th – 94th BMI percentiles Obesity >95th BMI percentiles |
| International Obesity Task Force [ | 2–18 years old | Overweight percentile curve passing though BMI = 25 kg/m2 at age 18; Obesity percentile curve passing through BMI = 30 kg/m2 at age 18 |
SD: Standard deviation; BMI: Body Mass Index for age and sex
Prevalence of overweight/obesity in school-aged children for different sub-Saharan African Countries
| Survey year | Investigators | Sub-Saharan African Country | Sample Size | Participants’ Ages (years) | Diagnostic criteria | Prevalence rates (%) | ||
|---|---|---|---|---|---|---|---|---|
| Overweight | Obesity | Combined overweight/obesity | ||||||
| 2009 | Manyanga T et al [ | Benin | 2681 | 13–17 | WHO | 11.2 | 0.6 | 11.8 |
| 2008–2009 | Dabone C et al [ | Burkina Faso | 649 | 7–14 | WHO | N/A | N/A | 2.3 |
| 2010 | Koueta F et al [ | Burkina Faso | 435 | 13–25 | IOTF | N/A | N/A | 8.6 |
| 2013 | Choukem SP et al [ | Cameroon | 1343 | 3–13 | WHO | 9.6 | 2.9 | 12.5 |
| 2007 | Manyanga T et al [ | Djibouti | 1711 | 13–17 | WHO | 18.8 | 5.2 | 24 |
| 2012 | Teshome T et al [ | Ethiopia | 559 | 10–19 | WHO and TSFT | 11–12.9 | 2.7–3.8 | N/A |
| 2013 | Alemu E et al [ | Ethiopia | 800 | 15–19 | CDC | 8.6 | 0.8 | 9.4 |
| 2014 | Askal T et al [ | Ethiopia | 845 | 9–14 | CDC | 8 | 1.8 | 9.8 |
| 2014 | Gebremichael B et al [ | Ethiopia | 463 | 10–18 | CDC | 9.9 | 2.8 | 12.7 |
| 2014 | Shegaze M et al [ | Ethiopia | 456 | 13–19 | WHO | 9.7 | 4.2 | 13.9 |
| 2016 | Desalew A et al [ | Ethiopia | 448 | 11–15 | CDC | 14.7 | 5.8 | 20.5 |
| 2006 | Manyanga T et al [ | Ghana | 6156 | 13–17 | WHO | 8.7 | 1.0 | 9.7 |
| 2008 | Kyallo F et al [ | Ghana | 344 | 9–14 | WHO | N/A | N/A | 19 |
| 2010 | Morge V et al [ | Ghana | 218 | 5–14 | WHO | N/A | N/A | 17.4 |
| 2010 | Kumah DB et al [ | Ghana | 500 | 10–20 | IOTF | 12.2 | 0.8 | 13 |
| 2012 | Mohammed H et al [ | Ghana | 270 | 5–15 | WHO | 15.8 | 10.9 | 26.7 |
| 2010 | Kramoh KE et al [ | Ivory Coast | 2038 | 6–18 | BMI | 4 | 5 | 9 |
| 2011 | Kamau JW et al [ | Kenya | 5325 | 10–15 | BMI | 8.7 | 3.1 | 11.8 |
| 2010 | Van den Berg VL [ | Lesotho | 221 | 16 | WHO, CDC and IOTF | 10.4–15.4 | 1.8–4.1 | 14.5–19 |
| 2009 | Manyanga T et al [ | Malawi | 2305 | 13–17 | WHO | 10 | 0.8 | 10.8 |
| 2014 | Oumar H et al [ | Mali | 984 | 5–19 | WHO and IOTF | 2.6–5.12` | 0.3–1.8 | N/A |
| 2010 | Manyanga T et al [ | Mauritania | 2028 | 13–17 | WHO | 24.3 | 3.4 | 27.7 |
| 2006 | Caleyachetty R et al. [ | Mauritius | 841 | 9–10 | IOTF | 17.4 | 4.9 | 22.3 |
| 1983–2013 | Ejike CECC [ | Nigeria | 21842⃰ | 3–20 | WHO, IOTF, TSFT and BMI | 5–12 | 0–5.8 | N/A |
| 2015 | Adam VY et al [ | Nigeria | 195 | 6–12 | WHO | 7.7 | 3.1 | 10.8 |
| 2011 | Faye J et al [ | Senegal | 2356 | 11–17 | N/A | N/A | 9.34 | N/A |
| 1999 | Stettler N et al [ | Seychelles | 5514 | 4–17 | IOTF | 12.6 | 3.8 | 16.4 |
| 2001–2004 | Armstrong MEG et al [ | South Africa | 10,195 | 6–13 | CDC | 15.8 | 3.9 | 19.7 |
| 2010 | Toriola AL et al [ | South Africa | 1172 | 10–16 | CDC | 10.1 | 4.9 | 15 |
| 2011 | Tathiah N et al [ | South Africa | 963 | 9–12 | CDC | 9 | 3.8 | 12.8 |
| 2013 | Pienaar AE [ | South Africa | 547 | 6–9 | CDC | 9.4 | 7.3 | 16.7 |
| 2007 | Aisha AMB et al [ | Sudan | 80 | 5–13 | CDC | 18.75 | 18.75 | 37.5 |
| 2011 | Nagwa MA et al [ | Sudan | 1138 | 10–18 | WHO | 10.8 | 9.7 | 20.5 |
| 2011 | Salman Z et al [ | Sudan | 304 | 6–12 | CDC | 14.8 | 10.5 | 25.3 |
| 2015 | El Raghi HA et al [ | Sudan | 290 | 10–18 | BMI | 26.2 | 28.3 | 54.5 |
| 2012 | Pangani IN et al [ | Tanzania | 1781 | 8–13 | WHO | 15.9 | 6.7 | 22.6 |
| 2015 | Kimario JT [ | Tanzania | 140 | 10–12 | IOTF, TSFT | N/A | N/A | 20–24.3 |
| 2014 | Chebet M et al [ | Uganda | 958 | 8–12 | BMI | 32.3 | 21.7 | 54 |
| 2013 | Nsibambi CAN [ | Uganda | 1929 | 6–9 | WHO and CDC | 7 | 4 | 11 |
| 2011 | Peltzer K et al [ | Uganda and Ghana | 5613 | 13–15 | BMI | 6.19 | 0.71 | 6.9 |
*Total sample size of narrative review of 42 studies conducted in Nigeria. BMI: Body mass index; CDC: Centres for Disease Control and Prevention; IOTF: International Obesity Task Force; N/A: Not available data; TSFT: Triceps skinfold thickness; UN: United Nations; WHO: World Health Organisation
Fig. 2The interaction between childhood and adolescence obesity or overweight and cardiovascular risk factors in sub-Saharan Africa